Both in vitro and in vivo studies demonstrated that blockade of βAR signaling pathways could inhibit multiple processes associated with tumor progression including cell proliferation, invasion, migration, angiogenesis, and tumor immune response [4, 5, 6, 7]. The gene discussed is ADRB2; the disease is neoplasm.